Envestnet Asset Management Inc Grifols Sa Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Grifols Sa stock. As of the latest transaction made, Envestnet Asset Management Inc holds 256,215 shares of GRFS stock, worth $2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
256,215
Previous 227,030 12.86%
Holding current value
$2 Million
Previous $1.43 Million 59.09%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$6.28 - $9.38 $183,281 - $273,755
29,185 Added 12.86%
256,215 $2.28 Million
Q2 2024

Aug 08, 2024
SELL
$6.27 - $7.7 $70,901 - $87,071
-11,308 Reduced 4.74%
227,030 $1.43 Million
Q1 2024

May 13, 2024
BUY
$5.47 - $11.38 $1,334 - $2,776
244 Added 0.1%
238,338 $1.59 Million
Q4 2023

Feb 13, 2024
BUY
$7.71 - $11.56 $244,715 - $366,914
31,740 Added 15.38%
238,094 $2.75 Million
Q3 2023

Nov 13, 2023
BUY
$8.91 - $10.91 $1.04 Million - $1.27 Million
116,694 Added 130.15%
206,354 $1.89 Million
Q2 2023

Aug 04, 2023
SELL
$7.14 - $9.29 $521,826 - $678,959
-73,085 Reduced 44.91%
89,660 $821,000
Q1 2023

May 11, 2023
BUY
$6.65 - $10.69 $792,965 - $1.27 Million
119,243 Added 274.11%
162,745 $1.2 Million
Q4 2022

Feb 07, 2023
SELL
$5.96 - $8.53 $36,481 - $52,212
-6,121 Reduced 12.34%
43,502 $369,000
Q3 2022

Nov 10, 2022
SELL
$5.95 - $14.3 $625,047 - $1.5 Million
-105,050 Reduced 67.92%
49,623 $306,000
Q2 2022

Aug 03, 2022
BUY
$10.6 - $13.28 $264,819 - $331,774
24,983 Added 19.26%
154,673 $1.84 Million
Q1 2022

May 04, 2022
BUY
$10.37 - $12.73 $337,533 - $414,348
32,549 Added 33.51%
129,690 $1.52 Million
Q4 2021

Feb 04, 2022
SELL
$10.21 - $15.27 $486,547 - $727,676
-47,654 Reduced 32.91%
97,141 $1.09 Million
Q3 2021

Oct 07, 2021
SELL
$14.07 - $17.3 $405,835 - $499,001
-28,844 Reduced 16.61%
144,795 $2.12 Million
Q2 2021

Aug 04, 2021
SELL
$16.62 - $18.94 $8.28 Million - $9.44 Million
-498,221 Reduced 74.16%
173,639 $3.01 Million
Q1 2021

May 04, 2021
SELL
$15.15 - $19.78 $621,059 - $810,861
-40,994 Reduced 5.75%
671,860 $11.6 Million
Q4 2020

Feb 02, 2021
SELL
$16.86 - $19.67 $764,482 - $891,896
-45,343 Reduced 5.98%
712,854 $13.1 Million
Q3 2020

Oct 09, 2020
SELL
$15.4 - $20.16 $2.11 Million - $2.77 Million
-137,238 Reduced 15.33%
758,197 $13.2 Million
Q2 2020

Jul 08, 2020
BUY
$18.24 - $21.45 $485,913 - $571,428
26,640 Added 3.07%
895,435 $16.3 Million
Q1 2020

Apr 23, 2020
SELL
$16.28 - $25.63 $863,930 - $1.36 Million
-53,067 Reduced 5.76%
868,795 $17.5 Million
Q4 2019

Feb 11, 2020
SELL
$19.57 - $23.52 $3.48 Million - $4.18 Million
-177,638 Reduced 16.16%
921,862 $21.5 Million
Q3 2019

Oct 17, 2019
BUY
$19.85 - $22.76 $176,684 - $202,586
8,901 Added 0.82%
1,099,500 $22 Million
Q2 2019

Aug 02, 2019
BUY
$17.59 - $21.1 $701,137 - $841,046
39,860 Added 3.79%
1,090,599 $23 Million
Q1 2019

May 10, 2019
BUY
$18.01 - $20.11 $506,026 - $565,030
28,097 Added 2.75%
1,050,739 $21.1 Million
Q4 2018

Feb 13, 2019
BUY
$17.44 - $21.53 $5.4 Million - $6.67 Million
309,855 Added 43.47%
1,022,642 $18.8 Million
Q3 2018

Nov 14, 2018
BUY
$19.97 - $21.96 $9.11 Million - $10 Million
456,223 Added 177.82%
712,787 $15.2 Million
Q2 2018

Aug 10, 2018
BUY
$20.16 - $24.68 $2.96 Million - $3.62 Million
146,616 Added 133.35%
256,564 $5.51 Million
Q1 2018

May 09, 2018
SELL
$20.31 - $24.95 $1.44 Million - $1.77 Million
-70,809 Reduced 39.17%
109,948 $2.33 Million
Q4 2017

Feb 20, 2018
BUY
$20.99 - $23.89 $229,567 - $261,284
10,937 Added 6.44%
180,757 $4.14 Million
Q3 2017

Nov 13, 2017
BUY
$20.07 - $21.89 $111,709 - $121,839
5,566 Added 3.39%
169,820 $3.72 Million
Q2 2017

Aug 14, 2017
BUY
N/A
164,254
164,254 $3.47 Million

Others Institutions Holding GRFS

# of Institutions
164
Shares Held
140M
Call Options Held
288K
Put Options Held
389K
View Full List

About Grifols SA

GRFS Quotes by TradingView
  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.31B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email